Primary autoimmune neutropenia of infancy and childhood in a cohort of patients from western Romania
- Authors:
- Cristian Jinca
- Margit Serban
- Emilia Ursu
- Andrei Munteanu
- Smaranda Arghirescu
View Affiliations
Affiliations: Department of Pediatrics, ‘Victor Babes’ University of Medicine and Pharmacy, 300041 Timisoara, Romania, Department of Onco‑Hematology, ‘Louis Turcanu’ Emergency Hospital for Children, 300011 Timisoara, Romania, Department of Puericulture and Neonatology, ‘Victor Babes’ University of Medicine and Pharmacy, 300041 Timisoara, Romania
- Published online on: January 25, 2021 https://doi.org/10.3892/etm.2021.9711
-
Article Number:
280
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
Neutropenia is commonly diagnosed in pediatric clinics. Due to the special vulnerability of neutropenic patients, the assessment of the etiopathogenic background of neutropenia is mandatory. In this retrospective cross‑sectional cohort study, we aimed to establish the status of primary autoimmune neutropenia (AIN) from the point of view of its clinical and biological features and its outcome in a cohort of pediatric patients. We recorded all of the 3,488 cases consecutively admitted to our hospital for different diagnoses but presenting neutropenia, during a period of 3 years (January 2016 to December 2018). We had to exclude 224 patients from the analysis due to incomplete data. Our study focused on patients with AIN or chronic benign neutropenia of infancy and childhood. In these patients, a granulocyte antibody screening by granulocyte immunofluorescence test (GIFT) and the granulocyte agglutination test (GAT) were performed. Regarding their pathogenic background, 0.1% of the patients presenting neutropenia were congenital forms, the rest being acquired forms. Primary AIN was encountered in 18 cases, representing approximately 0.5%. The median age at onset for primary AIN was 7.5 months. Male/female ratio in AIN was 1.94. In 72% of the patients with AIN, neutropenia was severe during the course of disease. In 3 patients, both GIFT and GAT were positive and in 8 patients, only GIFT was positive. For the remaining 7 patients (39%), both GIFT and GAT revealed negative results. 50% of the patients needed hospitalization, but only 3 patients presented severe infections. On‑demand G‑CSF was administered in 22% of the patients. Our study provides insight with regard to neutropenia, showing the high frequency and etiological diversity in childhood. Primary AIN is usually diagnosed by exclusion of the other causes of neutropenia. GIFT and GAT are useful, but rarely available diagnostic tools for the confirmation of primary AIN.
View References
|
1
|
Thomas AE and Simpson LA: A step-by-step
approach to paediatric neutropenia. Paediatrics and Child Health.
27:511–516. 2017.
|
|
2
|
Celkan T and Koç BŞ: Approach to the
patient with neutropenia in childhood. Turk Pediatri Ars.
50:136–144. 2015.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Newburger PE: Autoimmune and other
acquired neutropenias. Hematology Am Soc Hematol Educ Program.
2016:38–42. 2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Capsoni F, Sarzi-Puttini P and Zanella A:
Primary and secondary autoimmune neutropenia. Arthritis Res Ther.
7:208–214. 2005.PubMed/NCBI View
Article : Google Scholar
|
|
5
|
Farruggia P and Dufour C: Diagnosis and
management of primary autoimmune neutropenia in children: Insights
for clinicians. Ther Adv Hematol. 6:15–24. 2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Bux J and Chapman J: Report on the second
international granulocyte serology workshop. Transfusion.
37:977–983. 1997.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Donadieu J, Fenneteau O, Beaupain B,
Mahlaoui N and Chantelot CB: Congenital neutropenia: Diagnosis,
molecular bases and patient management. Orphanet J Rare Dis.
6(26)2011.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Bux J, Behrens G, Jaeger G and Welte K:
Diagnosis and clinical course of autoimmune neutropenia in infancy:
Analysis of 240 cases. Blood. 91:181–186. 1998.PubMed/NCBI
|
|
9
|
Walkovich K and Boxer LA: How to approach
neutropenia in childhood. Pediatr Rev. 34:173–184. 2013.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Dale DC: How I manage children with
neutropenia. Br J Haematol. 178:351–363. 2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Autrel-Moignet A and Lamy T: Autoimmune
neutropenia. Presse Med. 43(4 Pt 2):e105–118. 2014.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Heinzl MW, Schönbacher M, Dauber EM,
Panzer S, Mayr WR and Körmöczi GF: Detection of
granulocyte-reactive antibodies: A comparison of different methods.
Vox Sang. 108:287–293. 2015.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Bruin MC, von dem Borne AE, Tamminga RY,
Kleijer M, Buddelmeijer L and de Haas M: Neutrophil antibody
specificity in different types of childhood autoimmune neutropenia.
Blood. 94:1797–1802. 1999.PubMed/NCBI
|
|
14
|
Lyall EG, Lucas GF and Eden B: Autoimmune
neutropenia of infancy. J Clin Pathol. 45:431–434. 1992.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Farruggia P, Fioredda F, Puccio G,
Porretti L, Lanza T, Ramenghi U, Ferro F, Macaluso A, Barone A,
Bonanomi S, et al: Autoimmune neutropenia of infancy: Data from the
Italian Neutropenia Registry. Am J Hematol. 90:E221–E222.
2015.PubMed/NCBI View Article : Google Scholar
|
